DE69721824D1 - Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen - Google Patents

Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen

Info

Publication number
DE69721824D1
DE69721824D1 DE69721824T DE69721824T DE69721824D1 DE 69721824 D1 DE69721824 D1 DE 69721824D1 DE 69721824 T DE69721824 T DE 69721824T DE 69721824 T DE69721824 T DE 69721824T DE 69721824 D1 DE69721824 D1 DE 69721824D1
Authority
DE
Germany
Prior art keywords
macular
edems
carbonanhydrase
inhibitors
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69721824T
Other languages
English (en)
Other versions
DE69721824T2 (de
Inventor
Eric Sponsel
Alon Harris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADVANCED RESEARCH & TECHNOLOGY INSTITUTE, INDIANAP
Original Assignee
Indiana University Research and Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605642.9A external-priority patent/GB9605642D0/en
Application filed by Indiana University Research and Technology Corp filed Critical Indiana University Research and Technology Corp
Publication of DE69721824D1 publication Critical patent/DE69721824D1/de
Application granted granted Critical
Publication of DE69721824T2 publication Critical patent/DE69721824T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69721824T 1996-02-26 1997-02-25 Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen Expired - Lifetime DE69721824T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1225096P 1996-02-26 1996-02-26
US12250P 1996-02-26
GBGB9605642.9A GB9605642D0 (en) 1996-03-18 1996-03-18 Treatment of macular edema
GB9605642 1996-03-18
PCT/US1997/002874 WO1997030704A2 (en) 1996-02-26 1997-02-25 Use of carbonic anhydrase inhibitors for treating macular edema

Publications (2)

Publication Number Publication Date
DE69721824D1 true DE69721824D1 (de) 2003-06-12
DE69721824T2 DE69721824T2 (de) 2004-03-11

Family

ID=26308946

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69721824T Expired - Lifetime DE69721824T2 (de) 1996-02-26 1997-02-25 Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen

Country Status (26)

Country Link
EP (1) EP0954305B9 (de)
JP (1) JP4392481B2 (de)
KR (1) KR100471586B1 (de)
CN (1) CN1225582A (de)
AT (1) ATE239468T1 (de)
AU (1) AU727565B2 (de)
BG (1) BG64525B1 (de)
BR (1) BR9707674A (de)
CA (1) CA2247063C (de)
CZ (1) CZ299509B6 (de)
DE (1) DE69721824T2 (de)
DK (1) DK0954305T3 (de)
EA (1) EA001681B1 (de)
EE (1) EE03804B1 (de)
ES (1) ES2199348T4 (de)
HU (1) HU227161B1 (de)
IL (1) IL125912A0 (de)
IS (1) IS2053B (de)
MX (1) MXPA98006961A (de)
NO (1) NO320043B1 (de)
NZ (1) NZ331843A (de)
PT (1) PT954305E (de)
SK (1) SK284371B6 (de)
TR (1) TR199801665T2 (de)
WO (1) WO1997030704A2 (de)
YU (1) YU49422B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
WO1999044603A1 (en) * 1998-03-06 1999-09-10 Sponsel William E Composition and method for treating macular disorders
US5948801A (en) * 1998-03-09 1999-09-07 Alcon Laboratories, Inc. Treatment of retinal edema with brinzolamide
NZ509797A (en) * 1998-07-10 2003-11-28 Univ Sydney Prophylactic treatments of neovascularisation in macular degeneration using a steroid
GB9902453D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902459D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB0000625D0 (en) 2000-01-13 2000-03-01 Zeneca Ltd Chemical compounds
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor
JP2010513262A (ja) 2006-12-15 2010-04-30 ニコックス エス エイ カルボニックアンヒドラーゼ阻害剤誘導体
AR084194A1 (es) * 2010-12-09 2013-04-24 Fovea Pharmaceuticals Derivados de arilsulfonamida para la prevencion o el tratamiento de trastornos oftalmologicos especificos
EP3559005A1 (de) 2016-12-21 2019-10-30 Biotheryx Inc. Thienopyrrolderivate zur verwendung beim targeting von proteinen, zusammensetzungen, verfahren und verwendungen davon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
GB2223166B (en) * 1988-09-29 1992-03-18 American Cyanamid Co Stable ophthalmic preparations containing methazolamide
US5153192A (en) * 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors

Also Published As

Publication number Publication date
CZ269998A3 (cs) 2000-01-12
EP0954305B9 (de) 2010-08-04
NO983906L (no) 1998-10-19
KR100471586B1 (ko) 2005-07-11
AU1972197A (en) 1997-09-10
DK0954305T3 (da) 2003-08-25
PT954305E (pt) 2003-09-30
TR199801665T2 (xx) 1998-12-21
BR9707674A (pt) 2000-01-04
YU49422B (sh) 2006-01-16
BG102797A (en) 1999-09-30
EE9800263A (et) 1999-08-16
ATE239468T1 (de) 2003-05-15
IS4829A (is) 1998-08-20
ES2199348T4 (es) 2010-10-19
HU227161B1 (en) 2010-09-28
WO1997030704A2 (en) 1997-08-28
EP0954305B1 (de) 2003-05-07
CA2247063C (en) 2004-01-06
IL125912A0 (en) 1999-04-11
JP4392481B2 (ja) 2010-01-06
CN1225582A (zh) 1999-08-11
EP0954305A2 (de) 1999-11-10
CZ299509B6 (cs) 2008-08-20
HUP9902054A3 (en) 2001-07-30
IS2053B (is) 2005-10-14
EE03804B1 (et) 2002-08-15
BG64525B1 (bg) 2005-06-30
CA2247063A1 (en) 1997-08-28
MXPA98006961A (es) 2004-11-19
YU35398A (sh) 2001-12-26
ES2199348T3 (es) 2004-02-16
DE69721824T2 (de) 2004-03-11
WO1997030704A3 (en) 1997-09-25
NZ331843A (en) 2000-09-29
EA001681B1 (ru) 2001-06-25
SK284371B6 (sk) 2005-02-04
NO320043B1 (no) 2005-10-17
AU727565B2 (en) 2000-12-14
KR19990087242A (ko) 1999-12-15
JP2000506833A (ja) 2000-06-06
NO983906D0 (no) 1998-08-25
EA199800764A1 (ru) 1999-06-24
SK115198A3 (en) 2000-01-18
HUP9902054A1 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
DE69721824D1 (de) Verwendung von carbonanhydrase-hemmern zur behandlung von makulär-ödemen
DE69924641D1 (de) Behandlung von asthma anhand von mek-inhibitoren
DE69625690T2 (de) Verfahren zur vorbeugung und behandlung von allergien
DK0719154T3 (da) Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
ATE93138T1 (de) Verwendung insulin-sensiblisierender wirkstoffe zur behandlung von hypertonie.
DE69616376T2 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ATE411018T1 (de) Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
DE68917433D1 (de) Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
DE69431199T2 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69432626D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Desynchronisierungs-Erkankungen
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
UA66757C2 (en) Ophthalmologic composition of carbonic anhydrase inhibitors, method for treating or preventing macular edema or age-related macular degeneration
EE9700350A (et) COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
DE69502412T2 (de) Abgasbehandlungsmittel und Verfahren zur Behandlung von Abgas damit
ATE295731T1 (de) Olanzapine zur behandlung von drogenmissbrauch
ATE209861T1 (de) Verfahren zur behandlung von gefrorenen blattgemüse-portionen
NO984198L (no) FremgangsmÕte for behandling av aggresjon
RU94042315A (ru) Способ лечения язвенной болезни желудка и двенадцатиперстной кишки
ATA82393A (de) Verfahren zur behandlung von gasen
UA9553A (uk) Спосіб аутодермопластики коптюха

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ADVANCED RESEARCH & TECHNOLOGY INSTITUTE, INDIANAP

8364 No opposition during term of opposition